CSF sphingomyelins in Alzheimer’s disease, neurodegeneration, and neuroinflammation
Autumn Morrow, View ORCID ProfileDaniel J. Panyard, Yuetiva K. Deming, Erin Jonaitis, Ruocheng Dong, Eva Vasiljevic, View ORCID ProfileTobey J Betthauser, Gwendlyn Kollmorgen, Ivonne Suridjan, Anna Bayfield, Carol A. Van Hulle, Henrik Zetterberg, Kaj Blennow, Cynthia M. Carlsson, Sanjay Asthana, Sterling C. Johnson, View ORCID ProfileCorinne D. Engelman
doi: https://doi.org/10.1101/2022.01.19.22268636
Autumn Morrow
aDepartment of Population Health Sciences, University of Wisconsin-Madison, 610 Walnut Street, 707 WARF Building, Madison, WI 53726, United States of America
Daniel J. Panyard
bDepartment of Genetics, School of Medicine, Stanford University, 291 Campus Drive, Stanford, CA 94305, United States of America
Yuetiva K. Deming
aDepartment of Population Health Sciences, University of Wisconsin-Madison, 610 Walnut Street, 707 WARF Building, Madison, WI 53726, United States of America
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
dDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, 5158 Medical Foundation Centennial Building, Madison, WI 53705, United States of America
Erin Jonaitis
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
eWisconsin Alzheimer’s Institute, UW School of Medicine and Public Health, 610 Walnut Street, 9th Floor, Madison, WI 53726
Ruocheng Dong
aDepartment of Population Health Sciences, University of Wisconsin-Madison, 610 Walnut Street, 707 WARF Building, Madison, WI 53726, United States of America
Eva Vasiljevic
aDepartment of Population Health Sciences, University of Wisconsin-Madison, 610 Walnut Street, 707 WARF Building, Madison, WI 53726, United States of America
fCenter for Demography of Health and Aging, University of Wisconsin-Madison, 1180 Observatory Drive, Madison, WI 53706
Tobey J Betthauser
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
dDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, 5158 Medical Foundation Centennial Building, Madison, WI 53705, United States of America
Gwendlyn Kollmorgen
gRoche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany
Ivonne Suridjan
hRoche Diagnostics International Ltd, Forrenstrasse 2, 6343 Rotkreuz, Switzerland
Anna Bayfield
gRoche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany
Carol A. Van Hulle
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
dDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, 5158 Medical Foundation Centennial Building, Madison, WI 53705, United States of America
Henrik Zetterberg
iInstitute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, 43180 Mölndal, Sweden
jClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43180 Mölndal, Sweden
kUnited Kingdom Dementia Research Institute at UCL, London, WC1E6BT, United Kingdom
lDepartment of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1H0AL, United Kingdom
mHong Kong Center for Neurodegenerative Diseases, Hong Kong, China
Kaj Blennow
iInstitute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, 43180 Mölndal, Sweden
jClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43180 Mölndal, Sweden
Cynthia M. Carlsson
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
dDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, 5158 Medical Foundation Centennial Building, Madison, WI 53705, United States of America
nWilliam S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, United States of America
Sanjay Asthana
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
dDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, 5158 Medical Foundation Centennial Building, Madison, WI 53705, United States of America
nWilliam S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, United States of America
Sterling C. Johnson
cWisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, 600 Highland Avenue, J5/1 Mezzanine, Madison, WI 53792, United States of America
dDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, 5158 Medical Foundation Centennial Building, Madison, WI 53705, United States of America
nWilliam S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, United States of America
Corinne D. Engelman
aDepartment of Population Health Sciences, University of Wisconsin-Madison, 610 Walnut Street, 707 WARF Building, Madison, WI 53726, United States of America
Data Availability
The datasets analyzed in this study may be requested from the Wisconsin ADRC at https://www.adrc.wisc.edu/apply-resources.
Posted January 21, 2022.
CSF sphingomyelins in Alzheimer’s disease, neurodegeneration, and neuroinflammation
Autumn Morrow, Daniel J. Panyard, Yuetiva K. Deming, Erin Jonaitis, Ruocheng Dong, Eva Vasiljevic, Tobey J Betthauser, Gwendlyn Kollmorgen, Ivonne Suridjan, Anna Bayfield, Carol A. Van Hulle, Henrik Zetterberg, Kaj Blennow, Cynthia M. Carlsson, Sanjay Asthana, Sterling C. Johnson, Corinne D. Engelman
medRxiv 2022.01.19.22268636; doi: https://doi.org/10.1101/2022.01.19.22268636
CSF sphingomyelins in Alzheimer’s disease, neurodegeneration, and neuroinflammation
Autumn Morrow, Daniel J. Panyard, Yuetiva K. Deming, Erin Jonaitis, Ruocheng Dong, Eva Vasiljevic, Tobey J Betthauser, Gwendlyn Kollmorgen, Ivonne Suridjan, Anna Bayfield, Carol A. Van Hulle, Henrik Zetterberg, Kaj Blennow, Cynthia M. Carlsson, Sanjay Asthana, Sterling C. Johnson, Corinne D. Engelman
medRxiv 2022.01.19.22268636; doi: https://doi.org/10.1101/2022.01.19.22268636
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1533)
- Respiratory Medicine (916)
- Rheumatology (441)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)